Prognostic stratification of node-negative NSCLC patients: is it worthwhile?

Ann Thorac Surg. 2014 Oct;98(4):1527. doi: 10.1016/j.athoracsur.2014.04.112.

Authors

Giovanni Leuzzi¹, Emilio Bria², Gabriele Alessandrini³, Daniele Forcella³, Francesco Facciolo³

Affiliations

¹ Department of Surgical Oncology, Thoracic Surgery Unit, Regina Elena National Cancer Institute - IFO, Rome, Italy. Electronic address: gio.leuzzi@yahoo.it.
² Division of Medical Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
³ Department of Surgical Oncology, Thoracic Surgery Unit, Regina Elena National Cancer Institute - IFO, Rome, Italy.

PMID: 25282241
DOI: 10.1016/j.athoracsur.2014.04.112

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung / mortality*
Carcinoma, Non-Small-Cell Lung / pathology*
Female
Humans
Lung Neoplasms / mortality*
Lung Neoplasms / pathology*
Lymph Nodes / pathology*
Male